Search Results - joseph+marcotrigiano

3 Results Sort By:
Advanced Human Cell Line Technology for RSV Replication Complex Production and Antiviral Drug Discovery
This technology includes the NeurEx® mobile application, a groundbreaking tool designed for neurologists to conduct and document neurological examinations efficiently. Deployed on iPads, it integrates with a secure, cloud-based database, automating the computation of four key disability scales used in neuroimmunology. The app's robust design...
Published: 12/10/2024   |   Inventor(s): Cyril Le Nouen, Joseph Marcotrigiano, Ursula Buchholz, Peter Collins
Keywords(s):  
Category(s): Application > Research Materials, ResearchProducts > Human Cell Lines, TherapeuticArea > Infectious Disease
Glycoprotein Tetramer for Identifying Antigen-specific B Cells
Application Ectodomain of viral glycoprotein tetramers detects antigen-specific memory B Cells. Key Benefits Viral glycoprotein tetramers detect antigen-specific memory B cells in the peripheral blood and tissues. Hepatitis C virus E2 protein triggers immune response, which may yield an effective vaccine against hepatitis C virus. Market Summary Hepatitis...
Published: 10/28/2024   |   Inventor(s): Arash Grakoui, Joseph Marcotrigiano
Keywords(s): Antibody, Enzyme/Protein, Immunology/Inflammation
Category(s): TechPub Algolia > Vaccines, TechPub Algolia > Diagnostics
Methods to Produce Hepatitis C Virus E2 Protein
Invention Summary: Rutgers scientists have developed methods to produce and purify the ectodomain of HCV E2, a critical structural protein of the virus that has potential to serve as a vaccine candidate to prevent HCV infection. Efforts to study HCV, and to develop vaccines, have been impaired in part by the inability to produce sufficient quantities...
Published: 12/4/2024   |   Inventor(s): Joseph Marcotrigiano, Jillian Whidby
Keywords(s): Drug Discovery/Screening, Peptides
Category(s): Technology Classifications > Healthcare & Life Sciences, Technology Classifications > Therapeutics